204 References

REFERENCES:

Abel L, FO Sanchez, J. Oberti, NV Thuc, LV Hoa, VD Lap, E

Skamene, PH Lagrange, and E Schurr, Susceptibility to leprosy

is linked to the human NRAMP1 gene. J Infect Dis (1998); 177:

133-45.

Aguilar-Bryan L, Clement JP&Nelson DA Sulfonylurea receptors

and ATP-sensitive potassium ion channels. Methods Enzymol.

(1998); 292:732–744.

Akama T, Suzuki K, Tanigawa K, Kawashima A, Wu H & Nakata

N et al Whole genome tiling array analysis of Mycobacterium

leprae.RNA reveals high expression of pseudogenes and non-

coding regions. J Bacteriol (2009); 191:3321–7.

Allison, A C Two lessons from the interface of genetics and

medicine. Genetics. (2004); 166:1591-9.

Alter A, Alcaı¨s A, Abel, L& Schurr, E. Leprosy as a genetic

model for susceptibility to common infectious diseases. Human

Genetics (2008); 123: 227.

Alter A, de Leseleuc L, Van Thuc N, Thai VH, Huong NT & Ba

NN. Genetic and functional analysis of common MRC1 exon 7

polymorphisms in leprosy susceptibility. Hum Genet. (2010);

127:337-48.

205 References

Andersen JH "Studies in the Medieval Diagnosis of Leprosy in

Denmark: An Osteoarchaeological, Historical, and Clinical

Study." Danish Medical Bulletin 16(Supplement 9) (1969):1-142.

Anderson K, Cresswell P, Gammon M, Hermes J, Williamson A,

and Zweerink H. Endogenously synthesized peptide with an

endoplasmic reticulum signal sequence sensitizes antigen

processing mutant cells to class I-restricted cell-mediated lysis.

J Exp Med (1991); 174: 4 89–492.

Baohong Ji, Drug susceptibility testing of Mycobacterium

leprae.Int J Lepr,(1987); 55:830-835

Barrett JC, Fry B, Maller J, Daly MJ Haploview: Analysis and

visualization of LD and haplotype maps. Bioinformatics (2005)

21: 263-265

Barton RP A clinical study of the nose in lepromatous leprosy.

Lepr Rev. (1974); 45(2):135-44.

Bertranpetit, J & F Calafell, Genetic and geographical

variability in cystic fibrosis: evolutionary considerations. Ciba

Found Symp. (1996);197: 97-114

Beyene D, Aseffa A, Harboe M, Kidane D, Macdonald M, Klatser

PR, Bjune GA and Smith WC. Nasal carriage of Mycobacterium

leprae DNA in healthy individuals in Lega Robi village, Ethiopia.

Epidemiol. Infect.(2003); 131:841-848

206 References

Bochud P-Y, Hawn T, Siddiqui MR, Saunderson P, Britton S,

Abraham I, et al. Toll-Like Receptor 2 (TLR2) Polymorphisms Are

Associated with Reversal Reaction in Leprosy. J Infect Dis.

(2008); 197:253-61.

Boeck, CW & Danielssen, DC. Om Spedalskhed. Christiania

1847

Britton WJ, Lockwood DN. Leprosy. Lancet. Review

(2004)363(9416):1209-19.

Brown SG. The history of Leprosy, In: Leprosy Ed RC Hastings,

Churchill Livingstone, London(1985). Pp1-13.

Browne SG, Hogerzeil LM. B663 in the treatment of leprosy.

Preliminary report of a pilot trial.Lepr Rev( 1962);33:6-10.

Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA,

Antonarakis SE.Gene structure and chromosomal localization of

the human P2X7 receptor. Receptors Channels. (1998);5(6):347-

54.

Byrd SR, Gelber R and Bermudez LE. Roles of soluble

fibronectin and beta 1 integrin receptors in the binding of

Mycobacterium leprae to nasal epithelial cells. Clin. Immunol.

Immunopathol. (1993); 69:266-271.

Caillat-Zucman S , Daniel S, Djilali-Saiah I, Timsit J, Garchon

Henri-Jean, Boitard C and Bach JF. Family study of linkage

207 References

disequilibrium between TAP2 transporter and HLA class II genes

absence of TAP2 contribution to association with insulin-

dependent diabetes mellitus. Human Immunology. (1995);44(2):

80–87

Cambau E, Carthagena L, Chauffour A,Ji, B,& Jarlier, V.

Dihydropteroate synthase mutations in the folP1gene predict

dapsone resistance in relapsed cases of leprosy. Clin Infect Dis,

(2006); 42:238–241.

Cambau E, E Perani, I Guillemin, P Jamet, and B Ji.

Multidrugresistance to dapsone, rifampicin, and ofloxacin in

Mycobacterium leprae. Lancet (1997); 349:103–104.

Cambau E, P Bonnafous, E Perani, W Sougakoff, B Ji, and V

Jarlier. Molecular detection of rifampin and ofloxacin resistance

for patientswho experience relapse of multibacillary leprosy.

Clin. Infect. Dis. (2002); 34:39–45.

Caminero JA, Pena MJ, Campos-Herrero M., Rodriguez JC,

Garcia I, Cabrera , Lafoz C, Samper S, Takiff H, Afonso O, Pavon

JM, Torres MJ, van Soolingen D, Enarson DA and Martin C.

Epidemiological evidence of the spread of a Mycobacterium

tuberculosis strain of the Beijing genotype on Gran Canaria

Island. Am. J. Respir. Crit. Care Med. (2001);164: 1165-1170.

Cardona-Castro N, Beltran-Alzate JC, Romero-Montoya IM et al.

Identification and comparison of Mycobacterium lepraegenotypes

208 References

in two geographical regions of Colombia. Lepr Rev.(2009);

80:316–321.

Chopra I, Brennan P Molecular action of anti-mycobacterial

agents.. Tuber Lung Dis. (1997);78(2):89-98. Review.

Chused, TM, Apasov S & Sitkovsky M. Murine T lymphocytes

modulate activity of an ATP-activated P2Z-type purinoceptor

during differentiation. J Immunol.(1996): 157: 1371-80

Clark-Curtiss J E and G P Walsh. Conservation of genomic

sequences among isolates of Mycobacterium leprae. J. Bacteriol.

(1989); 171:48

Clark-Curtiss J E, and M A Docherty. A species-specific

repetitive sequence in Mycobacterium leprae DNA. J. Infect. Dis.

(1989); 159:7–15.

Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D,

Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F,

Badcock K, Basham D, Brown D, Chillingworth T, Connor R,

Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S,

Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L,

Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J,

Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston

JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology

of Mycobacterium tuberculosis from the complete genome

sequence. Nature. (1998) 11; 393(6685):537-44.

209 References

Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR,

Wheeler PR, Honoré N, Garnier T, Churcher C, Harris D,

Mungall K, Basham D, Brown D, Chillingworth T, Connor R,

Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N,

Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S,

Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM,

Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares

R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR,

Barrell BG. Massive gene decay in the leprosy bacillus. Nature.

(2001)22;409(6823):1007-11

Colonna M, Bresnahan M, Bahram S, Strominger JL & Spies

T.Allelic variants of the human putative peptide transporter

involved in antigen processing Proc. Natl. Acad. Sci. USA May

(1992); 89: 3932-3936.

Correa PA, Molina JF, Pinto LF, Arcos-Burgos M, Herrera M,

Anaya JM. TAP1 and TAP2 polymorphisms analysis in

northwestern Colombian patients with systemic lupus

erythematosus. Ann Rheum Dis(2003); 62:363–365.

Cox RA, K. Kempsell, L., Fairclough., and M.J. Colston, The 16S

ribosomal RNA of Mycobacterium leprae contains a unique

sequence which can be used for identification by the polymerase

chain reaction. J Med Microbiol (1991); 35:284-90.

Da Silva SA, Mazini PS, Reis PG, Sell AM, Tsuneto LT, Peixoto

PR & El Visentainer J, HLA-DR and HLADQ alleles in patients

210 References

from the south of Brazil: markers for leprosy susceptibility an

resistance. BMC Infectious Diseases. (2009); 9:134.

Davey TF, Rees RJ. The nasal discharge in leprosy: clinical and

bacteriological aspects. Lepr Rev. (1974); 45(2):121-34.

De Messias-Reason IJ, Boldt AB, Moraes Braga AC, Von Rosen

Seeling Stahlke E, Dornelles L, Pereira-Ferrari L, et al. The

association between mannan-binding lectin gene polymorphism

and clinical leprosy: new insight into an old paradigm. J Infect

Dis(2007); 196:1379-85

De Vries RR, NK Mehra, MC Vaidya, MD Gupte, P Meera Khan,

and JJ Van Rood, HLA-linked control of susceptibility to

tuberculoid leprosy and association with HLA-DR types. Tissue

Antigens. (1980); 16:294-304.

De Vries, RR, RF Fat, LE Nijenhuis, and JJ van Rood.HLA-

linked genetic control of host response to Mycobacterium leprae.

Lancet(1976); ii:1328–1330

de Wit MY, Klatser PR. Mycobacterium leprae isolates from

different sources have identical sequences of the spacer region

between the 16S and 23S ribosomal RNA genes Microbiology.

(1994); 140 :1983-7.

Dela Cruz E, Cellona RV, & Balagon, MVF Primary Drug

Resistance in Cebu, the Phillipines: cause of concern. Int. J.

Lepr otherMycobact. Dis. (1996); 64:253-256.

211 References

Dharmendra, Notes on leprosy, The Ministry of Health: Govt. of

India, 1969

Di Virgilio, F., P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A.

Morelli, M. Torboli, G. Bolognesi & O. R. Baricordi Nucleotide

receptors: an emerging family of regulatory molecules in blood

cells. Blood. (2001); 97:587-600.

Dommett RM, Klein N, Turner MW. Mannose-binding lectin in

innate immunity: past, present and future. Tissue Antigens.

(2006); 68:193-209.

Dzierzykray-Rogalski, Paleopathology of the Ptolemaic

inhabitants of Dakhleh Oasis (Egypt). J Hum Evol. (1980); 9:71-

74

Egan, TM, Samways & Z. Li Biophysics of P2X receptors.

Pflugers Arch, (2006); 452, 501-12.

Einstein MH, Leanza S, Chiu LG, Schlecht NF, Goldberg GL,

Steinberg BM, Burk RD Genetic variants in TAP are associated

with high-grade cervical neoplasia. Clin Cancer Res.(2009):

1019-23.

Faget GH, Pogge RC, Johansen FA, et al: The promin treatment

of leprosy: a progress report. Public Health Resp. (1943);

58:1792-1941

Fairbairn IP, CB Stober, DS Kumararatne & DA Lammas ATP-

mediated killing of intracellular mycobacteria by macrophages is

212 References

a P2X(7)-dependent process inducing bacterial death by

phagosome-lysosome fusion. J Immunol. (2001); 167:3300-7.

Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M,

Blaser MJ, Graham DY, Vacher S, Perez-Perez GI, Yamaoka Y,

Mégraud F, Otto K, Reichard U, Katzowitsch E, Wang X,

Achtman M, Suerbaum S Traces of human migrations in

Helicobacter pylori populations. Science. (2003);299:1582-5

Faustman D, Li XP, Lin HY, Fu YE, Eisenbarth G, Avruch J,

Guo J. Linkage of faulty major histocompatibility complex class

I to autoimmune diabetes. Science. (1991); 254:1756–1761.

Feng M, Yin B, Shen T, Ma Q, Liu L, Zheng J, Zhao Y, Qian K,

Liu D. TAP1 and TAP2 polymorphisms associated with

ankylosing spondylitis in genetically homogenous Chinese Han

population.Hum Immunol. (2009); 70(4):257-61.

Fernando SL, BM Saunders, R Sluyter, KK Skarratt, H

Goldberg, G B Marks, J S Wiley & W J Britton A polymorphism

in the P2X7 gene increases susceptibility to extrapulmonary

tuberculosis. Am J Respir Crit Care Med. (2007); 175:360-366.

Ferrari D, M Los, M K Bauer, P Vandenabeele, S Wesselborg & K

Schulze-Osthoff P2Z purinoreceptor ligation induces activation

of caspases with distinct roles in apoptotic and necrotic

alterations of cell death. FEBS Lett. (1999); 447:71-5.

213 References

Filliol I, Ferdinand S, Negroni L, Sola C & Rastogi N. Molecular

Typing of Mycobacterium tuberculosis Based on Variable Number

of Tandem DNA Repeats Used Alone and in Association with

Spoligotyping Journal of Clinical Microbiology,(July 2000):2520–

2524

Fitness J, Tosh K and Hil lAVS Genetics of susceptibility to

leprosy. Genes and Immunity(2002); 3:441–453

Fitness J, S Floyd, DK Warndorff, L Sichali, L Mwaungulu, AC

Crampin, PE Fine, and AV Hill, Large-scale candidate gene

study of leprosy susceptibility in the Karonga district of

northern Malawi. Am J Trop Med Hyg (2004); 71:330-40.

Foley PJ, Lympany PA, Puscinska E, Zielinski J, Welsh KI, du

Bois RM. Analysis of MHC encoded antigen-processing genes

TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit

Care Med. (1999); 160:1009–1014

Fontes ANB, Sakamuri RM, Baptista IM et al. Genetic diversity

of Mycobacterium lepraeisolates from Brazilian leprosy patients.

Lepr Rev. (2009); 80:302–315.

Franzblau SG Drug susceptibility testing of Mycobacterium

leprae in the BACTEC 460 system. Antimicrob Agents

Chemother (1989); 33:2115-2117.

Fsihi H and S T Cole. The Mycobacterium leprae genome:

systematic sequence analysis identifies key catabolic enzymes,

214 References

ATP-dependent transport systems and a novel polA locus

associated with genomic variability. Mol. Microbiol.(1995);

16:909–919.

Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL,

Cerundolo V. TAP deficiency syndrome.Clin.

Exp.Immunol.(2000); 212:173–178.

Galvez AA, Camarena A, Montaño M, Juarez A, Zamora AC,

Avila a GG, Checa M, Lopez GS, Alarcon GV, Granados J, Pardo

A, Zúñiga J, Selman M. Transporter associated with antigen

processing (TAP) 1 gene polymorphisms in patients with

hypersensitivity pneumonitis. Experimental and Molecular

Pathology(2008); 84:173–177.

Gillis T, Vissa V, Matsuoaka M et al. Characterization of Short

tandem repeats for genotyping Mycobacterium leprae. Lepr Rev.

(2009); 80: 250–260.

Global leprosy situation, 2007. Wkly Epidemiol Rec. (2007);

82:225-32.

Godal T B Myrvang, SS Froland, J Shao, and G Melaku,

Evidence that the mechanism of immunological tolerance

(―central failure‖) is operative in the lack of host resistance in

lepromatous leprosy. Scand J Immunol. (1972); 1:311-21

Gorodezky C, C Alaez, A Munguia, R Cruz, A Vazquez, A

Camacho, O Flores, M Rodriguez, and O Rodriguez, Molecular

215 References

mechanisms of MHC linked susceptibility in leprosy: towards

the development of synthetic vaccines. Tuberculosis (Edinb)

(2004); 84:82-92.

Gottesman MM, Pastan I. Biochemistry of multidrug resistance

mediated by the multidrug transporter. Annu.

Rev.Biochem.(1993); 62:385–427.

Goulart LR, Ferreira FR, Goulart IM: Interaction of TaqI

polymorphism at exon 9 of the vitamin D receptor gene with the

negative lepromin response may favor the occurrence of leprosy.

FEMS Immunol Med Microbiol. (2006); 48:91-98.

Grahames, CB, Michel AD, Chessell IP & Humphrey PP

Pharmacological characterization of ATP- and LPS-induced IL-

1beta release in human monocytes. Br J

Pharmacol.(1999);127:1915-21.

Groathouse NA, B Rivoire, H Kim,H Lee, S N Cho, P J Brennan

and V Vissa..Multiple Polymorphic loci for Molecular Typing of

Mycobacterium leprae Strains. J. Clin. Microbiol. (2004);

42:1666-1672.

Grosset JH, Guelpa-Laurus CC, Bobin P et al. Study of 3

documented relapses cases of multibacillary leprosy after

treatment with rifampicin. Int J Lepr,(1989); 57:607-614.

Gu B J, R Sluyter, K K Skarratt, A N Shemon, L P Dao-Ung, S J

Fuller, J A Barden, A L Clarke, S Petrou & J S. Wiley An Arg307

216 References

to Gln polymorphism within the ATP-binding site causes loss of

function of the human P2X7 receptor. J Biol Chem. (2004); 279:

31287-31295.

Gu BJ, W Zhang, RA Worthington, R Sluyter, P Dao-Ung, S

Petrou, JA Barden & JS Wiley. A Glu-496 to Ala polymorphism

leads to loss of function of the human P2X7 receptor. J Biol

Chem. (2001); 276:11135-42.

Gu, BJ & JS Wiley Rapid ATP-induced release of matrix

metalloproteinase 9 is mediated by the P2X7 receptor.

Blood,(2006); 107:4946-53.

Guinto RS, Cellona KV, Fajardo TT et al. Primary dapsone

resistance to leprosy in Cebu, Philippines. Int.J.Lepr.Other

Mycobact Dis. (1981); 41:427-430

Guthrie PB, Knappenberger J, Segal M, Bennett MVL, Charles

AC, Kater SB ATP released from astrocytes mediates glial

calcium waves. J Neurosci (1999);19:520–528.

Hackel C, S Houard, FPortaels, A van Elsen, A Herzog, and A

Bollen. Specific identification of Mycobacterium leprae by the

polymerasechain reaction. Mol. Cell. Probes (1990); 4:205–210.

Hall B, and Salipante S, Molecular Epidemiology of

Mycobacterium leprae as Determined by Structure- Neighbor

Clustering Journal of Clinical Microbiology. (2010); 48:1997–

2008.

217 References

Harrison PM, Gerstein M. Studying genomes through the aeons:

protein families, pseudogenes and proteome evolution. J Mol

Biol. (2002);318(5):1155-74.

Hartskeerl RA, MY de Wit, and PR Klatser, Polymerase chain

reaction for the detection of Mycobacterium leprae. J Gen

Microbiol. (1989); 135:2357-64.

Hatagima DV Opromolla, S Ura, MF Feitosa, B Beiguelman, and

H Krieger, No evidence of linkage between Mitsuda reaction and

the NRAMP1 locus. Int J Lepr Other Mycobact Dis. (2001); 69:99-

103.

Hawkey PM, Smith EG, Evans JT, Monk P, Bryan G, Mohamed

HH, Bardhan M& Pugh RNMycobacterial interspersed repetitive

unit typing of Mycobacterium tuberculosis compared to IS6110-

based restriction fragment length polymorphism analysis for

investigation of apparently clustered cases of tuberculosis. J.

Clin. Microbiol.(2003); 41:3514-3520.

Higgins CF. ABC transporters: from microorganisms to man.

Annu. Rev. Cell Biol. (1992); 8: 67–113.

Honore N, Cole ST. Molecular basis of rifampin resistance in

Mycobacterium leprae.Antimicrob Agents Chemother.(1993);

37:414–418.

Honore N, Perani E, Telenti A et al. A simple and rapid

technique for the detection of rifampin resistance in

218 References

Mycobacterium leprae. Int. J. Lepr. Other Mycobact. Dis.(1993);

61:600–604.

Honore N, Roche PW, Grosset JH and Cole ST. A method for

rapid detection of rifampicin-resistant isolates of Mycobacterium

leprae. Lepr. Rev.(2001); 72:441-448.

Humphreys B D, J Rice, S B Kertesy & G R Dubyak Stress-

activated protein kinase/JNK activation and apoptotic induction

by the macrophage P2X7 nucleotide receptor. J Biol

Chem,(2000); 275:26792-8.

Ishihara M, Ohno S, Mizuki N et al. Genetic polymorphisms of

the major histocompatibility complex encoded antigen

processing genes TAP and LMP in sarcoidosis. Human Immunol

(1996); 45:105-1 10.

Ishii N, Sugita Y, Nakajima H. Two sisters with leprosy. Journal

of Dermatology. (1993); 20:226.

Ismail A, Bousaffara R, Kaziz J, Jili J, el Kamel A, Tahar Sfar M,

Remadi S, Chouchane L. Polymorphism in transporter antigen

peptides gene (TAP1) associated with atopy in Tunisians. J

Allergy Clin Immunol(1997); 99:216-23.3: 110-7.

Jacobson RR, Hastings RC. Rifampin-resistant leprosy.

Lancet1976; 2:1304–5.

Jacobson RR and RC Hastings. Primary sulfone resistant

leprosy Int. J. Leprosy Other Mycobact.Dis. (1978); 46:116

219 References

Jacobson RR. Treatment of relapsed leprosy. Indian J Lepr

(1995);67:99-102

Jadhav RS, Kamble RR, Shinde VS, Edward S, Edward VK. Use

of reverse transcription polymerase chain reaction for the

detection of Mycobacterium leprae in the slit-skin smears of

leprosy patients Indian J Lepr (2005); 77:116-127.

Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ,

Howson, JMet al. Evidence for a cluster of genes on

chromosome 17q11-q21 controlling susceptibility to

tuberculosis and leprosy in Brazilians. Genes and Immunity,

(2004); 5:46.

Jamil S, S M Wilson, M Hacket, R Hussain, and N G Stoker. A

colorimetric PCR method for the detection of M. leprae in skin

biopsies from leprosy patients. Int. J. Lepr. Other Mycobact. Dis.

(1994); 62:512–520.

Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O,

Alpsoy E, Hamann L, Schumann RR, Tapping RI. Cutting edge:

A common polymorphism impairs cell surface trafficking and

functional responses of TLR1 but protects against leprosy. J

Immunol. (2007);178(12):7520-4.

Jopling WH and AC McDougall, Handbook of leprosy,

Butterworth Heinemann Ltd, 1988.

220 References

Kai M, M Matsuoka, N Nakata, S Maeda, M Gidoh, Y Maeda, K

Hashimoto, K Kobayashi, and Y Kashiwabara.

Diaminodiphenylsulfone resistance of Mycobacterium leprae

due to mutations in the dihydropteroate synthase gene. FEMS

Microbiol. Lett.(1999); 177:231–235.

Kai M, Nguyen Phuc NH, Nguyen HA, Pham TH, Nguyen KH,

Miyamoto Y, Maeda Y, Fukutomi Y, Nakata N, Matsuoka M,

Makino M, Nguyen TT. Analysis of drug-resistant strains of

Mycobacterium leprae in an endemic area of Vietnam.Clin Infect

Dis. (2011) ;52(5):e127-32.

Kaimal S, Thappa DM. Relapse in leprosy. Indian J Lepr(2009);

75:126–35.

Kaplan DL Biblical leprosy: an anachronism whose time has

come. J Am Acad Dermatol (1993); 28:507-10.

Katoch VM. Recent advances in the development of techniques

for diagnosis and epidemiology of leprosy. Indian J Lepr(1991);

63:362-370.

Keim P, Price LB, Klevytska AM, Smith KL, Schupp JM,

Okinaka R, Jackson PJ and Hugh-Jones ME Multiple-locus

variable-number tandem repeat analysis reveals genetic

relationships within Bacillus anthracis. J. Bacteriol. (2000);

182:2928-2936

221 References

Kellar-Wood HF, Powis SH, Gray J, Compston DA. MHC-

encodedTAP1 and TAP2 dimorphisms in multiple sclerosis.

Tissue Antigens(1994); 43: 129-32.

Khakh B S & R A North P2X receptors as cell-surface ATP

sensors in health and disease. Nature (2006);442: 527-32.

Kidgell C, Reichard U, Wain J, Linz B, Torpdahl M, Dougan G,

Achtman M. Salmonella typhi, the causative agent of typhoid

fever, is approximately 50,000 years old. Infect Genet Evol.

(2002);2(1):39-45.

Kim KR, Cho Kyun SH, Choi SJ, Jeong JH, Lee SH, Park CW

and Tae K. TAP1 and TAP2 Gene Polymorphisms in Korean

Patients with Allergic Rhinitis. J Korean Med Sci (2007); 22:

825-831.

Kim SK, Kang TJ, Chae GT, Chun JH, Shin HK, Kim JP, Ko YH

and Kim NH. The prevalence of folP1 mutations associated with

clinical resistance to dapsone, in Mycobacterium leprae isolates

from South Korea. Ann. Trop. Med. Parasitol. (2001); 95:429-

432.

Kim SK, Kim MJ, Chael GT and Sub JW* Detection of Rifampin

Resistance Mutation and Its Altered Nucleotide Sequences in

Mycobacterium leprae Isolated from Korean Patients with

Leprosy J. Microbiology. September (1996); Vol. 34, No. 3 : 236-

240

222 References

Kim SK, Lee SB, Kang TJ and Gue-Tae Chae Detection of gene

mutations related with drug resistance in Mycobacterium

lepraefrom leprosy patients using Touch-Down (TD) PCR FEMS

Immunology and Medical Microbiology (2003); 36: 27-32

Kimura M, Sakamuri RM, Groathouse NA, Brennan PJ and

Vissa V. Rapid Variable-Number Tandem Repeat (VNTR)

genotyping for Mycobacterium lepraeclinical specimens. J Clin

Microbiol,(2009); 47: 1757–1766.

Kiper N, Gerçeker F, Utine E, Yalçin E, Pekcan S, Cobanoğlu N,

Aslan A, Köse M, Doğru D, Ozçelik U&Ozgüç M.TAP1 and TAP2

gene polymorphisms in childhood cystic

echinococcosis.Parasitol Int.(2010); 59(2):283-5.

Klevytska A M, Price L B, Schupp J M, Worsham P L, Wong J &

Keim P. Identification and characterization of variable-number

tandem repeats in the Yersinia pestis genome. J. Clin. Microbiol.

(2001); 39:3179-3185.

Krahenbuhl JL and Adams LB Exploitation of gene knockout

mice models to study the pathogenesis of leprosy. Lepr Rev

(2000); 71: S170-S175.

Kramme S, Bretzel G, Panning M, Kawuma J and Drosten EC

Detection and quantification of Mycobacterium leprae in tissue

samples by real-time PCR. Med Microbiol Immunol(2004); 193:

189-193.

223 References

Kumar B, Dogra S, Kaur I. Epidemiological characteristics of

leprosy reactions: 15years experience from north India.

International Journal of Leprosy and Other

MycobacterialDiseases (2004); 72: 125.

Kurabachew M, Wondimu A and Ryon JJ Reverse transcription

PCR detection of M. leprae in clinical specimens. J Clin Microbiol

(1998); 36: 1352-1356.

Kuwata S, Yanagisawa M, Saeki H, Nakagawa H, Etoh T,

Tokunaga K, Juji T, Shibata Lack of primary association

between transporter associated with antigen processing genes

and atopic dermatitis. J Allergy Clin Immunol. (1995);96:1051-

60.

Kuzushita N, Hayashi N, Kanto T, Takehara T, Tatsumi T,

Katayama K, Ohkawa K, Ito A, Kasahara A, Moribe T, Sasaki Y,

Hori M.Involvement of transporter associated with antigen

processing 2 (TAP2) gene polymorphisms in hepatitis C virus

infection. Gastroenterology. (1999);116(5):1149-54

Lajoie J, Zijenah LS, Faucher MC et al Novel

TAP1polymorphisms in indigenous Zimbabweans: their

potentialimplications on TAP function and in human diseases.

Hum Immun(2003); 64 :823–829

Lavania M, Katoch VM, Singh HB, Das R, Sharma VD and

Chauhan DS et al Genetic polymorphism among Mycobacterium

224 References

leprae strains from Northern India, by using TTC repeats. Ind J

Lepr(2005); 77:60-65

Lavania M, Katoch K, Singh HB, Das R, Gupta AK, Sharma R et

al Predominance of three copies of rpoT gene repeats in

Mycobacterium leprae from Northern India.Infect Genet

Evol(2007); 7: 627-631

Lavania M, Katoch K, Sharma R, Sharma P, Das R, Gupta AK,

Chauhan DS & Katoch VM. Molecular typing of Mycobacterium

leprae strains from northern India using short tandem

repeats.Indian J Med Res (2011); 133: 618-626

Lawrence JG, Hendrix RW, Casjens S. Where are the

pseudogenes in bacterial genomes? Trends Microbiol(2001);

9:535–40.

Layouni S, Buresi C, Thomas P, Malafosse A and Dogu M. BRD2

and TAP-1 genes and juvenile myoclonic epilepsy. Neurol

Sci(2010); 31:53–56.

Lechat MF The paleoepidemiology of leprosy: an overview. Int J

Lepr Other Mycobact Dis (1999); 67: 460-70

Lee DH, Kim EG, Park KS, Jeong SW, Kong ID, Lee JW.

Characteristics of P2X7-like receptor activated by adenosine

triphosphate in HIT-T15 cells Pancreas. (2007);35(1):53-62

Lee S B, Kim S K, Kang T J, Chae G T, Chun J H, Shin H K, Kim

J P, Ko Y H& Kim N H. The prevalence of folP1mutations

associated with clinical resistance to dapsone, inMycoabcterium

225 References

lepraeisolates from South Korea. Ann Trop MedParasitol(2001);

95:429–432.

Levy L. Studies of the mouse foot pad techinique for cultivation

of Mycobacterium leprae 3. Doubling time during logarithmic

multiplication. Lepr. Rev. (1976); 47:103-106.

Li CM, SJ Campbell, DS Kumararatne, R Bellamy, C Ruwende,

K P McAdam, A V Hill & D A Lammas Association of a

polymorphism in the P2X7 gene with tuberculosis in a Gambian

population. J Infect Dis. (2002); 186:1458-62.

Lini N, Shankernarayan NP, and Dharmalingam K. Quantitative

real-time PCR analysis ofMycobacterium lepraeDNA and mRNA

in humanbiopsy material from leprosy and reactional

cases.Journal of Medical Microbiology.(2009); 58:753–759

Liu Y, Harrison PM, Kunin V, Gerstein M. Comprehensive

analysis of pseudogenesnin prokaryotes: widespread gene decay

and failure of putativehorizontally transferred genes. Genome

Biol. (2004);5:R64.

Liu C, Carrington M, Kaslow RA, Gao X, Rinaldo CR, Jacobson

LP, Margolick JB, Phair J, O'Brien SJ, Detels R. Association of

polymorphisms in human leukocyte antigen class I and

transporter associated with antigen processing genes with

resistance to human immunodeficiency virus type 1 infection J

Infect Dis. (2003);187(9):1404-10.

226 References

Maeda S, M Matsuoka, N Nakata, M Kai, Y Maeda, K

Hashimoto, H Kimura, K Kobayashi, and Y Kashiwabara.

Multidrug-resistantMycobacterium leprae from patients with

leprosy. Antimicrob. Agents Chemother. (2001); 45:3635–3639.

Malhotra D, Darvishi K, Lohra M et al. Association study of

major risk single nucleotide polymorphisms in the common

regulatory region of PARK2 and PACRG genes with leprosy in an

Indian population. Eur J Hum Genet. (2005) Dec 14; [Epub

ahead of print].

Malhotra D, Darvishi K, Sood S, Sharma S, Grover C, Relhan V,

Reddy BS, and Bamezai RN. IL-10 promoter single nucleotide

polymorphisms are significantly associated with resistance to

leprosy. Hum. Genet. (2005a); 118:295–300.

Martelli CM, Stefani MM, Gomes MK, Rebello PF, Peninni S and

Narahashi K. Single lesion paucibacillary leprosy: baseline

profile of the Brazilian Multicenter Cohort Study. International

Journal of Leprosy and OtherMycobacterial Diseases(2000); 68:

247.

Martinez AN, Britto CF, Nery JA, Sampaio EP, Jardim MR,

Sarno EN et al . Evaluation of real-time and conventional PCR

targeting complex 85 genes for detection of Mycobacterium

leprae DNA in skin biopsy samples from patients diagnosed with

leprosy. J Clin Microbiol(2006); 44: 3154-3159.

227 References

Matsuoka M, Maeda S, Kai M, Nakata N, Chae G T, Gillis T P,

Kobayashi K, Izumi S, and Kashiwabara Y. Mycobacterium

leprae typing by genomic diversity and global distribution of

genotypes. Int. J. Lepr.Other Mycobact. Dis.(2000); 68:121-128.

Matsuoka M, Kashiwabara Y & Namisato M. A Mycobacterium

leprae isolate resistant to dapsone, rifampin, ofloxacin and

sparfloxacin. Int J Lepr. (2000); 68:452–455.

Matsuoka M, Kashiwabara Y, Zhang L et al. A second case of

multidrug resistant Mycobacterium lepraeisolated from a

Japanese patient with relapsed lepromatous leprosy. Int J Lepr,

(2003); 71: 240–243.

Matsuoka M, Zhang L, Budiawan T, Saeki K and Izumi S.

Genotyping of Mycobacterium leprae on the basis of the

polymorphism of TTC repeats for analysis of leprosy

transmission. J. Clin. Microbiol.(2004); 42:741-45

Matsuoka M, Zhang L, Morris MF et al. Polymorphism in the

rpoT gene in Mycobacterium lepraeisolates obtained from Latin

American countries and its possible correlation with the spread

of leprosy. FEMS MicrobiolLett.(2005); 243: 311–315.

Matsuoka M, Teky B, Khin S A, Kyaw K, Tan E V, dela Cruz E,

Gelber R, Saunderson P, Balagon M A & Pannikar V.

Thefrequency of drug resistance mutations in Mycobacterium

lepraeisolates in untreated and relapsed leprosy patients from

228 References

Myanmar,Indonesia and the Philippines. Lepr Rev(2007);

78:343–352.

Matsuoka M. Recent advances in the molecular epidemiology of

leprosy.Nihon Hansenbyo Gakkai Zasshi. (2009);78(1):67-73.

Review

Matsuoka M. Drug resistance in leprosy. Review.Jpn J Infect

Dis. 2010 Jan; 63(1):1-7.

McDougall AC, Rees RJ, Weddell AG and Kanan MW. The

histopathology of lepromatous leprosy in the nose. J.

Pathol.(1975); 115:215-226.

Mehra NK, Rajalingam R, Mitra DK, Taneja V, Giphart MJ.

Variants of HLA-DR2/ DR51 group haplotypes andsusceptibility

to tuberculoid leprosy and pulmonary tuberculosisin Asian

Indians. Int J Leprosy (1995); 63: 241-248.

Mehra NK. Role of HLA linked factors in governing susceptibility

to leprosy and tuberculosis. Trop Med Parasitology (1992);

41:352-353.

Meima A, Richardus JH Habbema, JD. Trends in leprosy case

detection worldwide since 1985. Leprosy Review(2004);75: 19.

Meissner T, Brune W, Mayatepek E. Persistent

hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical

outcome and mutational analysis. Eur. J. Pediatr.(1997); 156:

754–757.

229 References

Middleton D, Megaw G, Gullen C, Hawkins S, Darke C, Savage

DA. TAP1 and TAP2 polymorphism in multiple sclerosis

patients. Hum lmmunol.(1994); 40:131-134.

Miller EN, Jamieson SE, Joberty C et al. Genome-wide scans for

leprosy and tuberculosis susceptibility genes in Brazilians.

Genes Immun, (2004); 5: 63–67.

Mira MT, A Alcais, N Van Thuc, VH Thai, NT Huong, NN Ba, A

Verner, TJ Hudson, L Abel, and E Schurr, Chromosome 6q25 is

linked to susceptibility to leprosy in a Vietnamese population.

Nat Genet (2003); 33 412-415.

Mira MT, Alcaı¨s A, VanThuc N et al. Susceptibility to leprosy is

associated with PARK2 e PACRG. Nature(2004); 427: 636–640.

Mischi E A, McDonald M,, Ranjit C, Sapkota B, Wells RD,

Siddiqui RM, Kaplan G and Hawn TR. Human TLR1 Deficiency

Is Associated with Impaired Mycobacterial Signaling and

Protection from Leprosy Reversal ReactionMay (2008);(2) e231

Misra N, V Ramesh, RS Misra, NP Narayan, MJ Colston, and I

Nath, Clinical utility of LSR/A15 gene for Mycobacterium leprae

detection in leprosy tissues using the polymerase chain

reaction. Int J Lepr Other Mycobact Dis (1995); 63: 35-41

Mohanty JG, Raible DG, McDermott LJ, Pelleg A, Schulman

ES.J Effects of purine and pyrimidine nucleotides on

intracellular Ca2+ in human eosinophils: activation of

230 References

purinergic P2Y receptors. Allergy Clin Immunol.

(2001);107(5):849-55.

Mokrousov IN, Sapozhnikova & Narvskaya O. Mycobacterium

tuberculosis co-existence with humans: making an imprint on

the macrophage P2X(7) receptor gene? J Med Microbiol, (2008);

57, 581-4.

Monot M, Honoré N, Garnier T, Araoz R, Coppée JY, Lacroix C,

Sow S, Spencer JS, Truman RW, Williams DL, Gelber R,

Virmond M, Flageul B, Cho SN, Ji B, Paniz-Mondolfi A, Convit J,

Young S, Fine PE, Rasolofo V, Brennan PJ, Cole ST. On the

origin of leprosy. Science. (2005); 308(5724):1040-2.

Monot M, Honore´ N, Balie`re N et al. Are variable-number

tandem repeats appropriate for genotyping Mycobacterium

leprae? J Clin Microbiol,(2008); 46: 2291–2297.

Monot M, Honoré N, Garnier T, Zidane N, Sherafi D, Paniz-

Mondolfi A, Matsuoka M, Taylor GM, Donoghue HD, Bouwman

A, Mays S, Watson C, Lockwood D, Khamesipour A, Dowlati Y,

Jianping S, Rea TH, Vera-Cabrera L, Stefani MM, Banu S,

Macdonald M, Sapkota BR, Spencer JS, Thomas J, Harshman

K, Singh P, Busso P, Gattiker A, Rougemont J, Brennan PJ,

Cole ST. Comparative genomic and phylogeographic analysis of

Mycobacterium leprae.Nat Genet. (2009); 41(12):1282-9.

Moraes M, Cardoso CC, Vanderborght and Pacheo AN, Genetics

of host response in leprosy. Lepr Rev (2006); 77: 189–202.

231 References

Morrison N.E and Marley G. Clofazamine studies with

deoxyribonucleic acids. Int. J. Lepr.Other. Mycobact. Dis., (1976);

44: 475-481.

Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM and

Hopewell PC. Tuberculosis in the homeless. A prospective study.

Am. J. Respir. Crit. Care Med. (2000);162:460-464.

Musser JM Antimicrobial agent resistance in mycobacteria:

molecular genetic insights. Clin Microbiol Rev. (1995); 8(4):496-

514.

Nedergaard M&Cotrina ML, Physiological and pathological

functions of P2X7 receptor in the spinal cord.Purinergic

Signal.(2009);5(2):223-32.

Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C,

Kalshekerl N, Smith JC and Markham AF Analysis of any point

mutation in DNA. The ampliflcation refractory mutation system

(ARMS) Nucleic Acids Research Volume 17 Number 7 198.

Nicke A, H G Baumert, J Rettinger, A Eichele, G Lambrecht, E

Mutschler & G Schmalzing P2X1 and P2X3 receptors form

stable trimers: a novel structural motif of ligand-gated ion

channels. EMBO J,(1998); 17: 3016-28.

Nino-Moreno P, Portales-Perez D, Hernandez-Castro B, Portales-

Cervantes L, Flores-Meraz V, Baranda, L Gomez-Gomez A,

Acuna-Alonzo V, Granados J & Gonzalez-Amaro R. P2X7 and

232 References

NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo

patients with pulmonary tuberculosis. Clin Exp Immunol,(2007);

148:469-77.

North R A. Molecular physiology of P2X receptors. Physiol

Rev,(2002);82:1013-67

Ogunbiyi AO, Daramola OO, Alese OO Prevalence of skin

diseases in Ibadan, Nigeria. Int J Dermatol. (2004);43(1):31-6.

Ortmann B, Copeman J, Lehner PJ, et al. A critical role for

tapasin in the assembly and function of multimeric MHC class

I-TAP complexes. Science (1997);277: 1306–1309.

Pattyn S R, D Ursi, M Ieven, V Raes, and P Jamet. Polymerase

chain reaction amplifying DNA coding for species-specific rRNA

of Mycobacterium leprae.Int. J. Lepr. Other Mycobact. Dis. (1992);

60:234–243

Pereira AC, Brito-de-Souza VN, Cardoso CC, Dias-Baptista IM,

Parelli FP, Venturini J, Villani-Moreno FR, Pacheco AG, Moraes

MO.Genetic, epidemiological and biological analysis of

interleukin-10 promoter single-nucleotide polymorphisms

suggests a definitive role for -819C/T in leprosy susceptibility.

Genes Immun. (2009);10(2):174-80. Epub 2008 Dec 25.

Petit JHS and Rees RJW. Sulphone resistance in leprosy. An

experimental and clinical study. Lancet 26: 673-674

233 References

Phetsukuri B, Sakamuri RM,Srisugnam S, Rudeeasankin

J.,Kimura M, Brennan PJ, and Vissa V. Molecular

Epidemiology of leprosy based on VNTR typing in Thailand. Lep

Review (2009); 80:2 80-289

Plikaytis BB, Gelber RH and Shinnick TM, Rapid and sensitive

detection of Mycobacterium leprae using a nested-primer gene

amplification assay. J Clin Microbiol (1990); 28:1913-7.

Powis SH, Tonks S, Mockridge I, Kelly AP, Bodmer JG

&Trowsdale J. Alleles and haplotypes of the MHC-encodedABC

transporters TAP1 and TAP2. Immunogenetics(1993); 37: 373–

380

Rajalingam R, Mehra NK, Jain RC, Myneedu VP, Pande JN.

Polymerase chain reaction based sequence specific

oligonucleotides hybridization analysis of HLA class II antigens

in pulmonary tuberculosis: relevance to chemotherapy and

disease severity. J Infect Dis (1996); 173:659-676.

Rajalingam R, Singal DPand Mehra NK. Transporter associated

with antigen-processing (TAP) genes and susceptibility to

tuberculoid leprosy and pulmonary tuberculosis. Tissue

Antigens (1997); 49: 168-172.

Ramu G. Clinical features and diagnosis of relapses in leprosy.

Indian J of leprosy (1995):67:45-49

234 References

Rani R, MA Fernandez-Vina, SA Zaheer, KR Beena, and P

Stastny, Study of HLA class II alleles by PCR oligotyping in

leprosy patients from north India. Tissue Antigens (1993); 42

133-7.

Rassendren F, G N Buell, C Virginio, G Collo, R A North & A

Surprenant. The permeabilizing ATP receptor, P2X7. Cloning

and expression of a human cDNA. J Biol Chem,(1997); 272:

5482-6.

Rau H, Nicolay A, Usadel KH, Finke R, Donner H, Walfish PG,

Badenhoop K.Polymorphisms of TAP1 and TAP2 genes in

Grave’sdisease. Tissue Antigens(1997); 49:16-22.

Rees R.J. Nasal infection and transmission of leprosy.Int. J.

Lepr. Other Mycobact.Dis.(1976); 44:108-109.

Remus N, A Alcais, and L Abel, Human genetics of common

mycobacterial infections. Immunol Res (2003); 28:109-29.

Richter E, M Duchrow, C Schluter, M Hahn, H D Flad, and J

Gerdes. Detection of Mycobacterium leprae by three-primer PCR.

Immunobiology(1994); 191:351–353..

Ridley DS and Wise MJ. Reaction of the dermis in leprosy. Int J

Lepr(1964); 32: 24-36.

Ridley DS, & Jopling WH. Classification of leprosy according to

immunity—a five-group system. Int. J. Lepr. Other Mycobact.

Dis. (1966);34:255–273.

235 References

Ridley DS. Bacterial indices. Leprosy in theory and practice.

Bristol: John Wright and Sons; pp.(1964); 620-622.

Riordan JR, Chang XB. CFTR, a channel with the structure of a

transporter. Biochim. Biophys. Acta (1992); 1101: 221–222.

Ritz U and Seliger B. The Transporter Associated With Antigen

Processing (TAP): Structural Integrity, Expression, Function,

and Its Clinical Relevance.Molecular Medicine (2001); 7(3):149–

158.

Robinson JH, Delvig AA. Diversity in MHC-II antigen

presentation. Immunology(2002);105:252-262.

Roger M, G Levee, S Chanteau, B Gicquel, and E Schurr, No

evidence for linkage between leprosy susceptibility and the

human natural resistance-associated macrophage protein 1

(NRAMP1) gene in French Polynesia. Int J Lepr Other Mycobact

Dis (1997); 65: 197-202.

Rogers, and Muir, Leprosy, John Wright, Bristol, 1940.

Roy S, W. McGuire, CG Mascie-Taylor, B Saha, SK Hazra, AV

Hill, and D Kwiatkowski, Tumor necrosis factor promoter

polymorphism and susceptibility to lepromatous leprosy. J

Infect Dis (1997); 176: 530-2.

Roy S, A Frodsham, B Saha, SK Hazra, CG Mascie-Taylor, and

AV Hill, Association of vitamin D receptor genotype with leprosy

type. J Infect Dis (1999; )179: 187-91.

236 References

Rueda-Faucz FR, Macagnan-Probst C, Petzl-Erler ML.

Polymorphism of LMP2, TAP1, LMP7 and TAP2 in Brazilian

amerindians and caucasoids: implications or the evolution of

allelic and haplotypic diversity. Eur. J. Immunogenet. (2000); 27:

5–16.

Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human P-

glycoprotein transports cyclosporin A and FK506. J. Biol. Chem.

(1993); 268: 6077–6080.

Sakamuri RM, Harrison J, Gelber R et al. A continuation: study

and characterisation of M. leprae short tandem repeat

genotypes and transmission of leprosy in Cebu, Philippines.

Lepr Rev, (2009); 80: 272–279.

Sambasivan V, Murthy K J, Reddy R, Vijayalakshimi V & Hasan

Q.P2X7 gene polymorphisms and risk assessment for

pulmonary tuberculosis in Asian Indians. Dis Markers,(2010);

28: 43-8.

Santos AR, AS Almeida, PN Suffys, MO Moraes, VF Filho, HJ

Mattos, JA Nery, PH Cabello, EP Sampaio, and EN Sarno,

Tumor necrosis factor promoter polymorphism (TNF2) seems to

protect against development of severe forms of leprosy in a pilot

study in Brazilian patients. Int J Lepr Other Mycobact Dis

(2000); 68:325-7.

Santos AR, PN Suffys, PR Vanderborght, MO Moraes, LM Vieira,

PH Cabello, AM Bakker, HJ Matos, TW Huizinga, TH Ottenhoff,

237 References

EP Sampaio, & EN Sarno, Role of tumor necrosis factor-alpha

and interleukin-10 promoter gene polymorphisms in leprosy. J

Infect Dis (2002); 186: 1687-91.

Sapkota BR, Ranjit C, Macdonald M. Reverse line probe assay

for the rapid detection of rifampicin resistance in Mycobacterium

leprae. Nepal Med Coll J. (2006 );8(2):122-7

Sapkota B R, Ranjit C, Neupane K D & Macdonald M.Developing

and evaluation of a novel multiple-primer PCRamplification

refractory mutation system for the rapid detection of mutations

conferring rifampicin resistance in codon 425 of the rpoBgene of

Mycobacterium leprae. J Med Microbiol. (2008); 57:179–184.

Sapkota BR, Macdonald M, Berrington WR, Misch EA, Ranjit C,

Siddiqui MR, Kaplan G, Hawn TR. Association of TNF, MBL, and

VDR polymorphisms with leprosy phenotypes.Hum

Immunol.(2010); 71:992-8.

Scemes E,Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F,

Carlsson SK, E, Keane RW, Dahl G.The pannexin 1 channel

activates the inflammasome in neurons and astrocytes.J Biol

Chem.(2009);284(27):18143-51.

Schauf V, Ryan S, Scollard D, Jonasson O, A Brown, K Nelson,

T Smith, and V Vithayasai, Leprosy associated with HLA-DR2

and DQw1 in the population of northern Thailand. Tissue

Antigens(1985); 26: 243-7.

238 References

Schuring R P, Hamann L, Faber W R, Pahan D, Richardus J H,

Schumann R R, and Oskam L. Polymorphism N248S in the

human Toll-like receptor 1 gene is related to leprosy and leprosy

reactions. J. Infect. Dis.(2009)199:1816–1819.

Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW

& Williams DL. The Continuing Challenges of Leprosy Clinical

Microbiology Reviews, (2006); p. 338–381.

Sehgal VN, Jain S and Charya SNPersisters, relapse

(reactivation), drug resistance and multidrug therapy (MDT):

uniform diagnostic guidelines for leprosy are needed.J.

Dermatol. (1996); 23:905-907

Sekar B, Elangeswaran N, Jayarama E, Rajendran M, Kumar

SS, Vijayaraghavan R, Anandan D. and Arunagiri K. Drug

susceptibility of Mycobacterium leprae: a retrospective analysis

of mouse footpad inoculation results from 1983 to 1997. Lepr.

Rev. (2002); 73:239-244

Sekar B, Arunagiri K, Nirmal Kumar B, Narayanan S, Menaka

K & Oommen PK. Detection of Mutations in folp1, rpoBand

gyrAgenes of M. lepraeby PCR- directsequencing – A rapid tool

for screening drugresistance in leprosy. Lepr Rev(2011);82:36–

45.

Shankarkumar U, Ghosh K, Badakere S and Mohanty D. Novel

HLA Class I Alleles Associated with Indian Leprosy Patients. J

Biomed Biotechnol (2003); 208-211.

239 References

Sharada RS, Hanumanth SR,Gaddam S, Jonnalagada S and

Valluri VL. ―Association Of Tap 1 And 2 Gene Polymorphisms

With HIV-TB Coinfection‖, Human immunology (2011)

(DOI:10.1016/j.humimm.2011.07.304).In Press

Sharma S, V Kumar, R Khosla, N Kajal, B Sarin & P Sehajpal

Association of P2X7 receptor +1513 (A-->C) polymorphism with

tuberculosis in a Punjabi population. Int J Tuberc Lung Dis,

(2010);14: 1159-63.

Shaw MA, Donaldson IJ, A Collins, CS Peacock, Z Lins-Lainson,

JJ Shaw, F Ramos, F Silveira, and JM Blackwell, Association

and linkage of leprosy phenotypes with HLA class II and tumour

necrosis factor genes. Genes Immun (2001); 2: 196-204.

Shepard C. The experimental disease that follows the injection

of human leprosy bacillus into footpads of mice. J Exp

Med(1960); 112: 445–454.

Shetty VP, Uplekar MW and Antia NH. Primary resistance to

single and multiple drugs in leprosy--a mouse footpad study.

Lepr. Rev. (1996); 67:280-286.

Shi L, Yang G, Fu Y et al Human TAP1 polymorphismsdetected

by denaturing gradient gel electrophoresis.

TissueAntigens(1997); 49:421–426

Shin YC, Lee H, Lee H, Walsh GP, Kim JD and Cho SN Variable

numbers of TTC repeats in Mycobacterium leprae DNA from

240 References

leprosy patients and use in strain differentiation. J Clin

Microbiol(2000); 38: 4535-4538.

Shinde V, Newton H, Sakamuri RM, Reddy V, Jain S, Joseph A,

Gillis T, Nath I, Norman G, & Vissa V, VNTR typing of

Mycobacterium lepraeinSouth Indian leprosy patients . Lepr

Rev(2009); 80: 290–301.

Siddiqui M R, S Meisner Tosh K Balakrishnan, S Ghei, S E

Fisher, M Golding, N P Shanker Narayan, T Sitaraman, U

Sengupta, R Pitchappan, and A V Hill. A major susceptibility

locus for leprosy in India maps to chromosome 10p13. Nat.

Genet.(2001); 27:439–441

Singal DP, Ye M, Qiu X and D'Souza M. Polyrnorphisrns in the

TAP2 gene and their association with rheumatoid arthritis. Clin

and Exp Rheumatol (1994); 12: 29-33.

Skamene E, E Schurr, and P Gros, Infection genomics: Nramp1

as a major determinant of natural resistance to intracellular

infections. Annu Rev Med (1998); 49: 275-87.

Sluyter R, Shemon A N & J S Wiley Glu496 to Ala

polymorphism in the P2X7 receptor impairs ATP-induced IL-1

beta release from human monocytes. J Immunol, (2004); 172:

3399-405.

Smith JM, Smith NH, O'Rourke M & Spratt BG. How clonal are

bacteria? Proc Natl Acad Sci U S A. (1993);90(10):4384-8

241 References

Smittipat N, Billamas P, Palittapongarnpim M, Thong-On A,

Temu MM, Thanakijcharoen P, Karnkawinpong O,

Palittapongarnpim P. Polymorphism of variable-number tandem

repeats at multiple loci in Mycobacterium tuberculosis.J Clin

Microbiol. (2005) Oct; 43(10):5034-43.

Soundravally R& Hoti S L Immunopathogenesis of dengue

hemorrhagic fever and shock syndrome: Role of TAP and HPA

gene polymorphism Human Immunology(2007); 68: 973–979.

Soundravally R & Hoti S L, Polymorphisms of the TAP 1 and 2

Gene MayInfluence Clinical Outcome of Primary Dengue Viral

Infection,Scandinavian Journal of Immunology (2008);67: 618–

625.

Spee P, Neefjes J. TAP-translocated peptides specifically bind

proteins in the ER, including gp96, protein disulfide isomerase

and calreticulin. Eur. J. Immunol. (1997); 27: 1441–2449.

Srisungngam S, Rudeeaneksin J, Wattanpokayakit S et al.

Typing of Thai clinical isolates of Mycobacterium lepraeand

analysis of leprosy transmission by polymorphism of tandem

repeats. Southeast Asian J Trop Med Public Health, (2007); 38:

714–720.

Stead WW, Senner WT, Reddick & J. P. Lofgren Racial

differences in susceptibility to infection by Mycobacterium

tuberculosis. N Engl J Med (1990);322: 422-427.

242 References

Storrs EE, Walsh GP, Burchfield HP & Binford CH Leprosy in

the armadillo: new model for biomedical research.

Science.(1974); 183:851-852.

Suh W, Mitchell E, Yang Y, Peterson P, Waneck G, Williams DB.

MHC class I molecules form ternary complexes with calnexin

and TAP and undergo peptide regulated interaction with TAP via

their extracellular domains. J. Exp.Med.(1996);184: 337–348.

Suneetha S, Arunthathi S, Job A, Date A, Kurian N and Chacko

CJ. Histological studies in primary neuritic leprosy: changes in

the nasal mucosa. Lepr. Rev. (1998); 69:358-366.

Supply P, Warren R M, Banuls A L, Lesjean S, Van Der Spuy

GD, Lewis LA, Tibayrenc M, Van Helden PD & Locht C. Linkage

disequilibrium between minisatellite loci supports clonal

evolution of Mycobacterium tuberculosis in a high tuberculosis

incidence area. Mol. Microbiol. (2003); 47:529-538.

Surprenant A, G Buell & R A North P2X receptors bring new

structure to ligand-gated ion channels. Trends Neurosci, (1995);

18:224-9.

Surprenant A, F Rassendren, E Kawashima, RA North & G Buell

The cytolytic P2Z receptor for extracellular ATP identified as a

P2X receptor (P2X7). Science, (1996); 272: 735-738.

243 References

Suzuki K, Nakata N, Bang PD, Ishii N, Makino M. High-level

expression of pseudogenes in Mycobacterium leprae. FEMS

Microbiol Lett(2006); 259:208–14.

Takeuchi K, Abe S, Masuda S, Yuta A, Majima Y, Sakakura Y.

Lack of association between gene polymorphism of transporters

associatedwith antigen processing and allergic rhinitis in a

Japanese population. Ann Otol Rhinol Laryngol(2002); 111: 460-

3.

Tang J, Freedman DO, Allen S et al TAP1 polymorphismsin

several human ethnic groups: characteristics, evolution,

andgenotyping strategies. Hum Immun (2001); 62:256–268

Tekaia Fet al. Analysis of the proteome of Mycobacterium

tuberculosis in silico. Tubercle Lung Disease (1999); 79: 329±342

Tekin D, Kayaalti Z, Dalgic N, Cakir E, Soylemezoglu T,

Kutlubay I & B. Aydin Kilic Polymorphism in the P2X7 gene

increases susceptibility to extrapulmonary tuberculosis in

Turkish children. Pediatr Infect Dis J, (2010); 29:779-82.

Tewari KM, Sinnathamby G, Rajagopal D, Laurence C,

Eisenlohr A. cytosolic pathway for MHC class II–restricted

antigen processing that is proteasome and TAP

dependent.Nature Immunology(2005); 14(12):1456-60

244 References

Tosh K, Meisner S, Siddiqui MR et al. A region of chromosome

20 is linked to leprosy susceptibility in a South Indian

population. J Infect Dis, (2002); 186:1190–1193.

Truman RW and Krahenbuhl JL Viable M. leprae as a research

reagent. Int J Lepr Other Mycobact Dis(2001); 69:1-12

Truman R, Fontes AB, De Miranda AB, Suffys P & Gillis T.

Genotypic variation and stability of four variable-number

tandem repeats and their suitability for discriminating strains of

Mycobacterium leprae. J. Clin. Microbiol.(2004); 42:2558-65.

Truman RW, Andrews KP, Robbins NK, Adams LB, James L.

Krahenbuhl J & Gillis TP. Enumeration of Mycobacterium leprae

Using Real-TimePCR PLOS neglected diseases(2008)

van Endert PM. Role of nucleotides and peptide substrate for

stability and functional state of the human ABC family

transporters associated with antigen processing. J Biol Chem.

(1999);274(21):14632-8.

Van Kaer L, Ashton-Rickardt PG, Ploegh HL & Tonegawa, S.

1992 TAP1 mutant mice are deficient in antigen presentation,

surface class I molecules and CD4-8+ T cells. Cell

(1992);71:1205-1214.

Visentainer JE, LT Tsuneto, MF Serra, PR Peixoto, and ML

Petzl-Erler. Association of leprosy with HLA-DR2 in a Southern

Brazilian population. Braz J Med Biol Res (1997); 30: 51-9.

245 References

Voss JC, Spee P, Momburg F, Neefjes JJ. (Membrane topology

and dimerization of the two subunits of the transporter

associated with antigen processing reveal a three domain

structure. J. Immunol. (1999); 163: 6679–6685.

Walker SL and Lockwood DN. The clinical and immunological

features of leprosy. Br Med Bull (2006); 77-78:103-21.

Watson CL and Lockwood DN. Single nucleotide polymorphism

analysis of European archaeological M. leprae DNA.. PLoS One.

(2009) 22;4(10):e7547DN

Weddell G & Palmer E The pathogenesis of leprosy. An

experimental approach. Lepr Rev. (1963);34:57-61.

Weng X, Wang Z, Liu J, Kimura M, William C, Black IV &

Brennan P.J. Identification and distribution of Mycobacterium

leprae genotypes in a region of high leprosy prevalence in China:

a 3-Year molecular epidemiological study.J Clin Microbiol (2007);

45:1728–1734

WHO India Leprosy situation in India epidemiological indicators.

(2007). NLEP Indicators as on 31.06.07.

Wiley JS, CE Gargett, W Zhang, MB Snook & GP Jamieson

Partial agonists and antagonists reveal a second permeability

state of human lymphocyte P2Z/P2X7 channel. Am J Physiol,

(1998); 275: C1224-31

246 References

Wiley J S, L P Dao-Ung, C Li, A N Shemon, B J Gu, M L Smart,

S J Fuller, J A Barden, S Petrou & R Sluyter An Ile-568 to Asn

polymorphism prevents normal trafficking and function of the

human P2X7 receptor. J Biol Chem,(2003); 278:17108-13.

Williams DL, TP Gillis and F Portaels. Geographically distinct

isolates of Mycobacterium leprae exhibit no genotypic diversity

by restriction fragment-length polymorphism analysis. Mol.

Microbiol.(1990); 4:1653–1659.

Williams DL, TP Gillis, RJ Booth, D Looker, and JD Watson, The

use of a specific DNA probe and polymerase chain reaction for

the detection of Mycobacterium leprae.J Infect Dis (1990);

162:193-200.

Williams DL, Spring E, Harris E, Roche P and Gillis TP.

Dihydropteroate synthase of Mycobacterium leprae and dapsone

resistance. Antimicrob. Agents Chemother.(2000); 44:1530–1537

Williams D L, Pittman T L, Gillis TP, Matsuoka M. &

Kashiwabara Y. Simultaneous detection of

Mycobacteriumlepraeand its susceptibility to dapsone using

DNA Heteroduplexanalysis. J Clin Microbiol (2001); 39:2083–

2088.

Williams DL & Gillis TP. Molecular detection of resistance in

Mycobacterium leprae. Lepr Rev (2004); 75:118–130.

Wolcott RR & Ross H. Exacerbation of leprosy during present

day treatment. Int J Lepr. (1953); 21(4:1):437-40.

247 References

World Health Organization. Chemotherapy of leprosy for control

programs. 675 Geneva WHO Technical Report Series, 1982.

Xiao J, L Sun, W Jiao, Z Li, S Zhao, H Li, J Jin, A Jiao, Y Guo, Z

Jiang, I Mokrousov & A Shen Lack of association between

polymorphisms in the P2X7 gene and tuberculosis in a Chinese

Han population. FEMS Immunol Med Microbiol (2009); 55:107-

11.

Xiao J, L Sun, H Yan, W Jiao, Q Miao, W Feng, X Wu, Y Gu, A

Jiao, Y Guo, X Peng & A Shen Metaanalysis of P2X7 gene

polymorphisms and tuberculosis susceptibility. FEMS Immunol

Med Microbiol. (2010); 1-6.

Xing Y, Liu J, Sakamuri RM et al. VNTR typing studies of

Mycobacterium lepraein China: assessment of methods and

stability of markers during treatment. Lepr Rev. (2009); 80: 261–

271.

Xu C, Qi S, Gao L, Cui H, Liu M, Yang H, Li K, Cao B.Genetic

polymorphisms of LMP/TAP gene and hepatitis B virus infection

risk in the Chinese population. J Clin Immunol.

(2007);27(5):534-41.

Yan G, Shi L, Faustmann D. Novel splicing of the human MHC-

encoded peptide transporter confers unique properties. J.

Immunol (1999);162: 852–856.

248 References

Young SK, Taylor Michael G, Jain S, Suneetha Lavanya M,

Suneetha S, Lockwood Diana NJ Microsatellite mapping of

Mycobacterium leprae populations in infected humans. J Clin

Microbiol(2004); 42: 4931-4936.

Young SK, Ponnighaus JM, Jain S and Young D, Use of Short

Tandem Repeat Sequences to Study Mycobacterium leprae in

Leprosy Patients in Malawi and India. PLoS Negl Trop Dis(2008);

2:e214.

Zhang L, Namisato M & Matsuoka M. A mutation at codon 516

in the rpoBgene Mycobacterium lepraeconfers resistance to

rifampin. Int J Lep Other Mycobact Dis (2004); 72:468–472.

Zhang L, Budiawan T & Matsuoka M. Diversity of potential

short tandem repeats in Mycobacterium leprae and application

for molecular typing. J Clin Microbiol, (2005); 43: 5221–5229.

Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, Cui Y, Yan

XX, Yang HT, Yang RD, Chu TS, Zhang C, Zhang L, Han JW, Yu

GQ, Quan C, Yu YX, Zhang Z, Shi BQ, Zhang LH, Cheng H,

Wang CY, Lin Y, Zheng HF, Fu XA, Zuo XB, Wang Q, Long H,

Sun YP, Cheng YL, Tian HQ, Zhou FS, Liu HX, Lu WS, He SM,

JY, Zhao X, Jiao YL, Mao LG, Yin G, Jiang ZX, Wang XD, Yu JP,

Hu ZH, Gong CH, Liu YQ, Liu RY, Wang DM, Wei D, Liu JX, Cao

WK, Cao HZ, Li YP, Yan WG, Wei SY, Wang KJ, Hibberd ML,

Yang S, Zhang XJ, Liu JJ Genomewide association study of

leprosy. N Engl J Med. (2009); 361(27):2609-18.